Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28659069 | 0.91 | USP2 (0.51) | CA1CA2ARMAPTCYP1A2 | |
| SCHEMBL30360750 | 0.84 | HPGD (0.61) | ARMAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL20510941 | 0.84 | HPGD (0.61) | ARMAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14094409 | 0.84 | MAPT (0.48) | CA1CA2ARMAPTCYP1A2 | |
| SCHEMBL14094399 | 0.84 | CA12 (0.47) | CA1CA2ARMAPTCYP19A1 | |
| SCHEMBL19292786 | 0.84 | CYP19A1 (0.50) | ARMAPTCYP19A1KMT2AHPGD | |
| SCHEMBL8148281 | 0.84 | CA1 (0.52) | CA1CA2MAPTCYP1A2CYP3A4 | |
| SCHEMBL2955745 | 0.83 | PARP15 (0.51) | CYP19A1HPGDALDH1A1PARP15PARP10 | |
| SCHEMBL3717515 | 0.81 | ERN1 (0.50) | CA1CA2ALDH1A1TDP1CA12 | |
| SCHEMBL25314031 | 0.81 | CA1 (0.53) | CA1CA2MAPTKMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8714724-B2 | Phase change inks containing novel synergist | XEROX CORPORATION (US) | 2014-05-06 | — | — | US | disclosed |
| US-8524891-B2 | Tetraazaporphyrin-based compounds and their uses | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2013-09-03 | — | — | US | disclosed |
| US-8524891-B2 | Tetraazaporphyrin-based compounds and their uses | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2013-09-03 | — | — | US | disclosed |
| US-8524891-B2 | Tetraazaporphyrin-based compounds and their uses | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2013-09-03 | — | — | US | disclosed |
| US-20090215105-A1 | Tetraazaporphyrin-Based Compounds and Their Uses | NATIONAL SCIENCE FOUNDATION | 2009-08-27 | — | — | US | disclosed |
| US-20090215105-A1 | Tetraazaporphyrin-Based Compounds and Their Uses | NATIONAL SCIENCE FOUNDATION | 2009-08-27 | — | — | US | disclosed |
| US-20090215105-A1 | Tetraazaporphyrin-Based Compounds and Their Uses | NATIONAL SCIENCE FOUNDATION | 2009-08-27 | — | — | US | disclosed |
| EP-1912921-A2 | TETRAAZAPORPHYRIN-BASED COMPOUNDS AND THEIR USES | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College (US) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007009101-A2 | TETRAAZAPORPHYRIN-BASED COMPOUNDS AND THEIR USES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2007009101-A2 | TETRAAZAPORPHYRIN-BASED COMPOUNDS AND THEIR USES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215105-A1 | Tetraazaporphyrin-Based Compounds and Their Uses | DDB1, PPIF, SSBP1 | CA1 1041/4885CA2 367/4885AR 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.